Cancer cell membranes and intracellular components

Cancer cell membranes and intracellular components refers to the collective structural and functional elements of a malignant cell, including the plasma membrane and various organelles such as the nucleus, mitochondria, and lysosomes. The plasma membrane of cancer cells often undergoes significant alterations, including changes in lipid composition and the overexpression of specific surface proteins, which can be exploited for targeted therapy (Van Meer et al., 2008). Intracellularly, the nucleus is a primary target for many chemotherapeutic agents that interfere with DNA replication, while mitochondria are targeted to trigger apoptosis in cells that have developed resistance to standard treatments (Modica-Napolitano & Singh, 2002). Drugs like doxorubicin and paclitaxel interact with these components by binding to DNA or stabilizing microtubules, respectively, to halt cell division (Szakács et al., 2006). However, because these components are fundamental to all living cells, the lack of high specificity remains a major therapeutic challenge, often resulting in significant off-target effects and systemic toxicity. Consequently, this term is generally considered a broad category of targets rather than a single, specific molecular entity.

Other names

Tumor cell membraneCancer cell organellesCytoplasmic componentsIntracellular compartmentsPlasma membrane and intracellular machinery

Drugs targeting these components act through various mechanisms including DNA intercalation, inhibition of microtubule assembly, disruption of mitochondrial membrane potential, and induction of oxidative stress via photodynamic action.